1 thought on “The industry response of Shenyang Weikang Hospital”
Elaine
Jingcheng Pharmacy is not optimistic about the future of the Victoria Office Hospital The future of the investment behavior of Shenyang Victoria, the industry has more pessimistic views, thinking that a chain pharmacy that has no experience in handling medical treatment is used to invest in technology -led Large -scale comprehensive hospitals, whether it is subsequent funds, talent strength, or brand building, facing many difficulties, the chance of success is small. This hospitals seem to have nothing to do with drug operations itself. At present, the Beijing medical market is over -competitive, and it is unrealistic to invest in new hospitals. More than two years ago, the Golden Elephant also considered taking over a specialized hospital from the level of the joint -stock company to extend to the medical market. At that time, the Xicheng District Government also supported it, but because the problems of hospital personnel resettlement were too complicated, the treatment was not smooth enough. In the end Can't talk. Xu Jun told reporters that the most important thing is that the current national medical market policies are unclear and unstable, which has a great impact on investor confidence. In the past two years, there are many investment in other industries in other industries, but there are not many success. I will not go to the comprehensive hospital for the time being, but the company is considering investing in millions of dollars to organize a clinic for value -added services to members. In the future, it will be open to the society with the concept of "family doctor". ICS Pharmaceutical Group was founded in 2000, which was developed on the basis of 1993 operations of drug wholesale, commercial allocation, and Shenyang Weikang Pharmaceutical Chain Co., Ltd. The group integrates commercial distribution, logistics distribution, hospital pure sales, chain retail, drug production, import and export trade. At present, 124 chain pharmacies have been opened in Shenyang, Dalian, Benxi and other places, with an annual turnover of more than one billion yuan, and are the largest pharmaceutical retail companies in Shenyang.
Jingcheng Pharmacy is not optimistic about the future of the Victoria Office Hospital
The future of the investment behavior of Shenyang Victoria, the industry has more pessimistic views, thinking that a chain pharmacy that has no experience in handling medical treatment is used to invest in technology -led Large -scale comprehensive hospitals, whether it is subsequent funds, talent strength, or brand building, facing many difficulties, the chance of success is small.
This hospitals seem to have nothing to do with drug operations itself. At present, the Beijing medical market is over -competitive, and it is unrealistic to invest in new hospitals. More than two years ago, the Golden Elephant also considered taking over a specialized hospital from the level of the joint -stock company to extend to the medical market. At that time, the Xicheng District Government also supported it, but because the problems of hospital personnel resettlement were too complicated, the treatment was not smooth enough. In the end Can't talk. Xu Jun told reporters that the most important thing is that the current national medical market policies are unclear and unstable, which has a great impact on investor confidence. In the past two years, there are many investment in other industries in other industries, but there are not many success. I will not go to the comprehensive hospital for the time being, but the company is considering investing in millions of dollars to organize a clinic for value -added services to members. In the future, it will be open to the society with the concept of "family doctor".
ICS Pharmaceutical Group was founded in 2000, which was developed on the basis of 1993 operations of drug wholesale, commercial allocation, and Shenyang Weikang Pharmaceutical Chain Co., Ltd. The group integrates commercial distribution, logistics distribution, hospital pure sales, chain retail, drug production, import and export trade. At present, 124 chain pharmacies have been opened in Shenyang, Dalian, Benxi and other places, with an annual turnover of more than one billion yuan, and are the largest pharmaceutical retail companies in Shenyang.